Rethinking Precision Oncology in the Age of Functional Data

by Biotech Newsroom


Contributed Commentary by Jim Foote, First Ascent Biomedical 

December 11, 2025 | Few words strike fear into our hearts more than “cancer.” For me, it was October 19, when I heard, “Jim, Trey has cancer.” In an instant, I was thrust into a world I didn’t understand, filled with unfamiliar terms and life-or-death decisions. My son was fighting cancer, and I was given the most complex problem of my life. 

After eight months of grueling chemotherapy, surgery confirmed the tumor was dead. We thought we had won. But three months later,…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC